Skip to main content

Critical Care Reviews Newsletter

Newsletter 587  |  March 12th, 2023

Please support our work to share science

More CCR23 Faculty Announcements this Week

Welcome to the 587th Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature over the past seven days.

The highlights of this week's edition are randomised controlled trials comparing immediate with staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease & intrapartum azithromycin with placebo on neonatal sepsis and death; systematic reviews and meta analyses evaluating immediate vs delayed coronary angiography for out-of-hospital cardiac arrest & anaerobic coverage in the antibiotic treatment of aspiration pneumonia; and observational studies on ultrasound-assessment of central venous catheter-related thrombosis & hyperoxemia after reperfusion in cardiac arrest patients.

There is also a statement on aspiration pneumonia; narrative reviews on imaging of central nervous system ischemia & guideline-based management of acute respiratory failure and acute respiratory distress syndrome; an editorial on perioperative dialysis; and commentaries on mechanical power & prescribing prolonged intermittent renal replacement therapy.

If you only have time to read one review article this week, try this one on pleural effusions in critically ill patients.

Support CCR

You can support Critical Care Reviews, from as little as the price of a cup of coffee per month or make a one-off donation. We are not-for-profit and make all our content free to view. Our aim is to share science for the benefit of all - please join us in this mission.

Research

Randomised Controlled Trials

Systematic Review & Meta Analyses

Observational Studies

Protocols

Reviews

Clinical

COVID-19
Neurological
Circulatory
Respiratory
Gastrointestinal
Renal
Sepsis
Trauma
Paediatrics
Miscellaneous

Pre-Clinical

I hope you find this newsletter useful.


Until next week

Rob